Heron Therapeutics Inc (HRTX)

Equity Ratio

2.74%

Quarterly · Period ending:

HRTX logo

HRTX Equity Ratio

Latest reported2.74%
HRTX Quarterly Equity Ratio (81.90% → 2.74%)
High-resolution chart · PNG

HRTX equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
2.7384%
3.711%
5.6015%
5.9791%
-11.7446%
-12.069%
-14.4334%
-18.1201%
-17.3928%
-15.497%
-15.2684%
-12.1231%
-19.5225%
-5.1743%
5.4082%
8.2551%
-8.9095%
8.7526%
25.3741%
33.725%
39.6072%
63.1087%
66.8895%
71.0591%
74.8884%
76.3075%
78.7537%
72.6386%
74.1764%
76.1401%
80.0902%
86.3902%
84.5923%
50.2806%
55.9676%
33.8869%
48.5179%
53.8938%
-31.4914%
18.0961%
67.468%
82.8604%
85.6832%
89.5985%
90.5982%
80.5021%
82.2383%
87.7831%
90.0661%
88.2407%
90.7924%
79.1505%
74.8175%
84.4913%
92.5784%
93.1283%
78.1041%
77.5844%
81.008%
88.0529%
85.403%
7.2922%
45.2078%
61.8978%
58.4647%
74.9006%
75.9245%
15.8709%
28.7563%
56.4201%
64.3898%
62.5464%
73.3385%
77.3363%
79.7673%
89.0527%
90.253%
56.8053%
69.9032%
87.8691%
90.2068%
92.0348%
69.1604%
77.6798%
81.1203%
86.8716%
83.1903%
87.8788%
90.8597%
77.6427%
85.6176%
85.6802%
85.5365%
85.8162%
86.8532%
82.7315%
81.5539%
83.4727%
81.5598%
83.8918%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.